Equities

N4 Pharma PLC

N4P:LSE

N4 Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.80
  • Today's Change0.00 / 0.00%
  • Shares traded18.36k
  • 1 Year change-56.76%
  • Beta-0.7727
Data delayed at least 20 minutes, as of May 17 2024 13:10 BST.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2023, cash reserves at N4 Pharma PLC fell by 892.42k. Cash Flow from Financing totalled 315.90k or 16,200.00% of revenues. In addition the company used 1.21m for operations while cash from investing totalled 780.00.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.0042
Tangible book value per share0.004
More ▼

Balance sheet in GBPView more

N4 Pharma PLC appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio14.86
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.